A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/2004
12/16/2004	WO2004078940A3 USE OF ANTISENSE OLIGONUCLEOTIDES OR siRNA TO SUPPRESS EXPRESSION OF eIF-5A1
12/16/2004	WO2004010951A3 Method of treating tumors
12/16/2004	WO2003015667A8 Method and intra sclera implant for treatment of glaucoma and presbyopia
12/16/2004	US20040254378 2-Methanesulfone group; Side effect reduction; Nonsteroidal Antiinflammatory
12/16/2004	US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders
12/16/2004	US20040254249 Nonsteroidal antiinflammatory agents
12/16/2004	US20040254233 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
12/16/2004	US20040254212 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
12/16/2004	US20040254211 Alpha v integrin receptor antagonists
12/16/2004	US20040254198 Respiratory system disorders; asthma; chronic obstructive pulmonary disease
12/16/2004	US20040254197 Injections for eye tissues containing drug bonded to polyethlene glycol
12/16/2004	US20040254192 2,4,5-trisubstituded thiazolyl derivatives and their antiinflammatory activity
12/16/2004	US20040254189 Jnk inhibitors
12/16/2004	US20040254185 Endothelial growth factor antagonist; angiogenesis inhibitor; skin disorders; anticancer agents; endometriosis; Crohn's disease; leukemia; antiarthritic agents; vision defects
12/16/2004	US20040254176 Hypotensive agents; cardiovascular disorders; antidiabetic agents; skin disorders;kidney disorders; headaches; vision defects; strokes; synergistic mixture of amlodipine, benazepril and hydrochlorothiazide; oral administering
12/16/2004	US20040253709 Schistosoma protein for use in treatment of organ-specific autoimmune diseases
12/16/2004	US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders
12/16/2004	US20040253318 Preventing, alleviating symptoms of a skin condition with a complexes, such as lauryliminodipropionic acid tocopheryl phosphate; penetrating and absorption into skin; inflammation, erythema, wound, burn, dermatitis, gingivitis, sunburn, heat burn, psoriasis; cosmetics
12/16/2004	US20040253293 Rate controlled release of a pharmaceutical agent in a biodegradable device
12/16/2004	US20040253276 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization
12/16/2004	US20040253245 Modulating an immune response by administering a modulator of Notch intracellular domain protease activity, including modulators of presenilin and presenilin-dependent gamma secretase activity; immunotherapy; treatment of Alzheimer's disease
12/16/2004	US20040253226 administering to the animals angiogenesis inhibitors comprising kallikreins such as prostate specific antigens (PSA), hydrolase enzymes homologs or fragments; prophylaxis of cancer, arthritis and vision defects
12/16/2004	CA2528497A1 Tricyclic compound
12/16/2004	CA2528179A1 Piperidinyl prostaglandin e analogs
12/16/2004	CA2528006A1 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents
12/16/2004	CA2526509A1 Connective tissue growth factor antibodies
12/15/2004	EP1486497A1 Novel pyridone derivative
12/15/2004	EP1486494A1 N-substituted benzothiophenesulfonamide derivative
12/15/2004	EP1486214A1 Botulinum toxins for treating muscle spasm
12/15/2004	EP1485388A2 Topiramate salts and compositions comprising and methods of making and using the same
12/15/2004	EP1485375A1 Pyrimidine compounds
12/15/2004	EP1485374A1 Pyrimidine compounds
12/15/2004	EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485368A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity
12/15/2004	EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485360A2 Sodium channel blockers
12/15/2004	EP1485359A2 Sodium channel blockers
12/15/2004	EP1485353A1 New inhibitors of histone deacetylase
12/15/2004	EP1485109A1 Vascular therapeutics
12/15/2004	EP1485099A1 Inhibitors of histone deacetylase
12/15/2004	EP1485092A1 Use of rapamycin for inhibiting of cell death
12/15/2004	EP1485089A1 Combination treatments for chemokine-mediated diseases
12/15/2004	EP1485088A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
12/15/2004	EP1485086A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane as nmda, 5ht3, and neuronal nicotinic receptor antagonists
12/15/2004	EP1485084A1 Use of an l-ascorbic acid salt to prepare a pharmaceutical composition for ophtalmic topical use capable of improving the level of l-ascorbic acid in the eye
12/15/2004	EP1401862A4 Peptide compounds for counteracting reactive oxygen species and free radicals
12/15/2004	EP1226160B1 Novel antiarrhythmic peptides
12/15/2004	EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
12/15/2004	EP1207899B1 Treatment of allergic rhinitis with certain vasoactive amine binding proteins
12/15/2004	EP1175222B1 Monthly doses of glycopeptide antibiotics for long-term prevention of streptococcus pneumoniae infections
12/15/2004	EP1119543B1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor
12/15/2004	EP1068180B1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors
12/15/2004	EP0968290B1 Anti-alphavbeta3 humanized monoclonal antibodies
12/15/2004	CN1555488A Lymphatic endothelial cells materials and methods
12/15/2004	CN1555367A 3-substituted-4-pyrimidone derivatives
12/15/2004	CN1555355A Substituted 4-aminocyclohexanol derivatives
12/15/2004	CN1555268A Therapeutic agents comprising pro-apoptotic proteins
12/15/2004	CN1555267A Method of treating middle ear infections
12/15/2004	CN1555262A Novel 4,5-dihydro-1H-pyrazole derivatives having CB*-antagonistic activity
12/15/2004	CN1554389A Drink for treating xerophthalmia and alacrimia
12/15/2004	CN1554352A Therapeutic agent for eye inflammatory disease containing roxithromycin
12/15/2004	CN1554345A Acicluvir gel preparation for eye and its preparing method
12/15/2004	CN1179970C Purine derivatives
12/15/2004	CN1179961C Sulfonamides for treatment of endothelin-mediated disorders
12/15/2004	CN1179960C Indole derivatives and their use for treamtent of osteoporosis amongst other applications
12/15/2004	CN1179958C Cyclic substituted aminomethyl compounds and medicaments containing said compounds
12/15/2004	CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them
12/15/2004	CN1179944C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/15/2004	CN1179752C Benzodiazapine compounds containing imidazole propanamido and its preparing process and application
12/14/2004	US6831186 Antiinflammatory agents; autoimmune disease
12/14/2004	US6831172 Cross-linked hyaluronic acids and medical uses thereof
12/14/2004	US6831106 Vitamin D analogues
12/14/2004	US6831097 2,3-diaryl-pyrazolo[1,5-B]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors
12/14/2004	US6831091 Anticancer agents
12/14/2004	US6831083 Pyrazoline derivative or tetrahydropyridazine derivative and medicinal use thereof
12/14/2004	US6831075 Heterocyclic substituted pyrazolones
12/14/2004	US6831065 Anti-inflammatory compounds and uses thereof
12/09/2004	WO2004105784A1 Class iii slrp agonists for the reduction of blood vessel formation
12/09/2004	WO2003105800A3 Film-shaped mucoadhesive administration form for administering cannabis active ingredients
12/09/2004	WO2003097082A3 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
12/09/2004	WO2003072114A9 Vascular therapeutics
12/09/2004	WO2003053219A3 Methods for slowing senescence and treating and preventing diseases associated with senescence
12/09/2004	US20040249161 Biphenyl-derivatives as p38-kinase inhibitors
12/09/2004	US20040249159 Novel piperidin-2,6-dione disulphate salts and their use for the treatment of stress related affective disorders
12/09/2004	US20040249139 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss
12/09/2004	US20040248962 Ketorolac tromethamine compositions for treating or preventing ocular pain
12/09/2004	US20040248947 N-(3- and 4-substituted phenyl)-2-(arylamino)-benzamides; aralkylation of the 2-primary amine with a benzaldehyde or a pyrid-4-yl carbaldehyde; anticarcinogenic, antitumor agents; enzyme inhibitors of vascular endothelial growth factors
12/09/2004	US20040248944 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
12/09/2004	US20040248936 such as (R)-1-{4-[4-(4-Phenoxy-2-propyl-phenoxy)-butoxy]-benzenesulfonyl}-azetidine-2-carboxylic acid, used as peroxisome proliferator-activated receptor agonists; hypoglycemic agents
12/09/2004	US20040248920 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/09/2004	US20040248889 Analgesics; synthesis
12/09/2004	US20040248886 Neuronal disorders, autoimmune diseases, cancer, cardiovascular diseases; such as 4-Chloro-N-{5-[1-(4-trifluoromethyl-benzyl)-piperidin-3-ylsulfamoyl]-25 thiophen-2-ylmethyl)-benzamide
12/09/2004	US20040248885 Use of thiazole derivatives for preparing a medicine for protecting mitochondria
12/09/2004	US20040248847 Neutralized with dextran; adjustment of ph; prevent eye damage
12/09/2004	US20040248820 Administering 2-phthalimidoglutaric acid; vision defects; antitumor agents; anticancer agents
12/09/2004	US20040248206 Connective tissue growth factor antibodies
12/09/2004	US20040248188 Methods for using tetanus toxin for benificial purposes in animals (mammals)
12/09/2004	US20040247681 An acrylated polypropylene glycol or 1,2-propylene oxide adduct copolymerized with an acrylic silyl ester or an acrylic ketone; controlled release ocular inserts; glaucoma, cataracts
12/08/2004	EP1484327A1 Nitrogenous heterocyclic compound and medicine thereof
12/08/2004	EP1484054A1 Drug delivery system for the subconjunctival administration of fine grains

1 ... 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 ... 531